Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus and Viral RNA in Relation to Surface Type and Contamination Concentration.


Journal

Applied and environmental microbiology
ISSN: 1098-5336
Titre abrégé: Appl Environ Microbiol
Pays: United States
ID NLM: 7605801

Informations de publication

Date de publication:
25 06 2021
Historique:
pubmed: 9 5 2021
medline: 8 7 2021
entrez: 8 5 2021
Statut: ppublish

Résumé

The transmission of SARS-CoV-2 is likely to occur through a number of routes, including contact with contaminated surfaces. Many studies have used reverse transcription-PCR (RT-PCR) analysis to detect SARS-CoV-2 RNA on surfaces, but seldom has viable virus been detected. This paper investigates the viability over time of SARS-CoV-2 dried onto a range of materials and compares viability of the virus to RNA copies recovered and whether virus viability is concentration dependent. Viable virus persisted for the longest time on surgical mask material and stainless steel, with a 99.9% reduction in viability by 122 and 114 h, respectively. Viability of SARS-CoV-2 reduced the fastest on a polyester shirt, with a 99.9% reduction within 2.5 h. Viability on the bank note was reduced second fastest, with 99.9% reduction in 75 h. RNA on all surfaces exhibited a 1-log reduction in genome copy number recovery over 21 days. The findings show that SARS-CoV-2 is most stable on nonporous hydrophobic surfaces. RNA is highly stable when dried on surfaces, with only 1-log reduction in recovery over 3 weeks. In comparison, SARS-CoV-2 viability reduced more rapidly, but this loss in viability was found to be independent of starting concentration. Expected levels of SARS-CoV-2 viable environmental surface contamination would lead to undetectable levels within 2 days. Therefore, when RNA is detected on surfaces, it does not directly indicate the presence of viable virus, even at low cycle threshold values.

Identifiants

pubmed: 33962986
pii: AEM.00526-21
doi: 10.1128/AEM.00526-21
pmc: PMC8231718
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0052621

Subventions

Organisme : Medical Research Council
ID : MC_PC_19064
Pays : United Kingdom
Organisme : UKRI | Medical Research Council (MRC)
ID : MC_PC_19064

Commentaires et corrections

Type : CommentIn

Références

Clin Infect Dis. 2021 May 18;72(10):e652-e654
pubmed: 32857833
Environ Sci Technol. 2017 Jul 5;51(13):7318-7325
pubmed: 28599109
J Hosp Infect. 2021 Feb;108:189-196
pubmed: 33259882
Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):14857-14863
pubmed: 32527856
J Hosp Infect. 2020 Nov;106(3):570-576
pubmed: 32828864
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Clin Infect Dis. 2020 Jul 08;:
pubmed: 32634826
Lancet Microbe. 2020 May;1(1):e10
pubmed: 32835322
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Emerg Microbes Infect. 2020 Dec;9(1):1415-1417
pubmed: 32496967
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13188-93
pubmed: 22847443
J Infect Dis. 2020 Sep 1;222(7):1098-1102
pubmed: 32691828
Sci Total Environ. 2021 Jan 10;751:142317
pubmed: 33182011
Influenza Other Respir Viruses. 2020 Jul;14(4):470-471
pubmed: 32129925
J R Soc Interface. 2018 Feb;15(139):
pubmed: 29491178
Clin Infect Dis. 2021 Jun 1;72(11):2052-2061
pubmed: 32985671
Emerg Infect Dis. 2020 Jun;26(6):1343-1345
pubmed: 32163030
Appl Environ Microbiol. 2010 May;76(9):2712-7
pubmed: 20228108
mSphere. 2020 Jul 1;5(4):
pubmed: 32611701
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
Clin Infect Dis. 2021 May 11;:
pubmed: 33972994
Proc Natl Acad Sci U S A. 2020 Jun 2;117(22):11875-11877
pubmed: 32404416
J Hosp Infect. 2000 Sep;46(1):61-6
pubmed: 11023725
JAMA. 2020 Apr 28;323(16):1610-1612
pubmed: 32129805
Virol J. 2020 Oct 7;17(1):145
pubmed: 33028356
Sci Rep. 2021 Jan 13;11(1):984
pubmed: 33441775
Sci Total Environ. 2021 Jan 20;753:141710
pubmed: 32891988

Auteurs

Susan Paton (S)

Public Health England, National Infection Service, Porton Down, Wiltshire, United Kingdom.

Antony Spencer (A)

Public Health England, National Infection Service, Porton Down, Wiltshire, United Kingdom.

Isobel Garratt (I)

Public Health England, National Infection Service, Porton Down, Wiltshire, United Kingdom.

Katy-Anne Thompson (KA)

Public Health England, National Infection Service, Porton Down, Wiltshire, United Kingdom.

Ikshitaa Dinesh (I)

Public Health England, National Infection Service, Porton Down, Wiltshire, United Kingdom.

Paz Aranega-Bou (P)

Public Health England, National Infection Service, Porton Down, Wiltshire, United Kingdom.

David Stevenson (D)

Public Health England, National Infection Service, Porton Down, Wiltshire, United Kingdom.

Simon Clark (S)

Public Health England, National Infection Service, Porton Down, Wiltshire, United Kingdom.

Jake Dunning (J)

Emerging Infections and Zoonoses, National Infection Service, Public Health England, London, United Kingdom.
NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, University of Oxford, Oxford, United Kingdom.

Allan Bennett (A)

Public Health England, National Infection Service, Porton Down, Wiltshire, United Kingdom.

Thomas Pottage (T)

Public Health England, National Infection Service, Porton Down, Wiltshire, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH